PTC
ASND icon

Private Trust Company’s Ascendis Pharma A/S ASND Stock Holding History

Private Trust Company’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11
Closed -$2.19K – 2550
2025
Q3 		$2.19K Buy
+11
New +$2.05K ﹤0.01% 2334
2025
Q2 		– Sell
-26
Closed -$4.05K – 2471
2025
Q1 		$4.05K Buy
+26
New +$3.71K ﹤0.01% 2101
2024
Q3 		– Sell
-39
Closed -$5.32K – 2288
2024
Q2 		$5.32K Hold
39
– – ﹤0.01% 1902
2024
Q1 		$5.9K Sell
39
-5
-11% -$714 ﹤0.01% 1854
2023
Q4 		$5.54K Buy
44
+11
+33% +$1.1K ﹤0.01% 1882
2023
Q3 		$3.09K Sell
33
-12
-27% -$1.12K ﹤0.01% 2031
2023
Q2 		$4.02K Buy
+45
New +$3.92K ﹤0.01% 1943

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return